Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleNew Research, Disorders of the Nervous System

Cocaine Exposure Modulates Perineuronal Nets and Synaptic Excitability of Fast-Spiking Interneurons in the Medial Prefrontal Cortex

Megan L. Slaker, Emily T. Jorgensen, Deborah M. Hegarty, Xinyue Liu, Yan Kong, Fuming Zhang, Robert J. Linhardt, Travis E. Brown, Sue A. Aicher and Barbara A. Sorg
eNeuro 1 October 2018, 5 (5) ENEURO.0221-18.2018; https://doi.org/10.1523/ENEURO.0221-18.2018
Megan L. Slaker
1Department of Integrative Physiology and Neuroscience, Translational Addiction Research Center, Washington State University, Vancouver, Washington 98686
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily T. Jorgensen
3School of Pharmacy and Department of Neuroscience, University of Wyoming, Laramie, Wyoming 82071
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah M. Hegarty
2Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, Oregon 97239
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinyue Liu
4Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York 12180
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yan Kong
4Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York 12180
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yan Kong
Fuming Zhang
4Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York 12180
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fuming Zhang
Robert J. Linhardt
4Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York 12180
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert J. Linhardt
Travis E. Brown
3School of Pharmacy and Department of Neuroscience, University of Wyoming, Laramie, Wyoming 82071
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sue A. Aicher
2Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, Oregon 97239
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara A. Sorg
1Department of Integrative Physiology and Neuroscience, Translational Addiction Research Center, Washington State University, Vancouver, Washington 98686
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Barbara A. Sorg
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Extended Data
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Cocaine exposure increases locomotor activity, and PV intensity is correlated with WFA intensity. Data are the mean ± SEM. A, Timeline of experiment. B, Infrared photocell beam breaks the first 15 min after saline or cocaine injection (15 mg/kg, i.p.). A single cocaine exposure increased the locomotor response compared with the habituation (Hab) day. C, Repeated cocaine increased locomotor activity compared with their Hab day and with saline controls on day 4 (D4) and D5. D, Significant positive correlation between WFA staining intensity in WFA+/PV+ cells and cocaine-induced locomotor activity on day 2 when intensity was examined 2 h after 5 d of cocaine exposure (Fig. 1-1, available at https://doi.org/10.1523/ENEURO.0221-18.2018.f1-1, for all correlations). E, Representative photomicrograph of PV cells (red) with (yellow arrows) and without (blue arrows) WFA (green). WFA was also observed surrounding non-PV cells (white arrows). Scale bar, 100 µm. F, Significant positive correlation between WFA and PV intensity in rats 24 h after 5 d of saline (open circles) or cocaine (closed circles) exposure. For B and C: *p < 0.05, compared with saline group; +p < 0.05, compared with Hab group.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Cocaine exposure alters the intensity of WFA and PV in the prelimbic PFC. A, B, Intensity of WFA surrounding PV cells (WFA+/PV+ cells; A) and intensity of WFA surrounding all non-PV cells (WFA+/PV− cells; B) 2 or 24 h after acute (1 d) or repeated (5 d) saline (S) or cocaine (C) exposure in the prelimbic PFC. C, D, Intensity of PV cells that are surrounded by WFA (PV+/WFA+ cells; C) and intensity of PV+/WFA− cells (D) 2 or 24 h after acute or repeated saline or cocaine. N = 6–8 rats/group. *p < 0.05, compared with saline group.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Cocaine exposure alters intensity of WFA and PV in the infralimbic PFC. A, B, Intensity of WFA surrounding PV cells (WFA+/PV+ cells; A) and intensity of WFA surrounding all non-PV cells (WFA+/PV− cells; B) 2 or 24 h after acute (1 d) or repeated (5 d) saline (S) or cocaine (C) exposure in the infralimbic PFC. C, D, Intensity of PV cells that are surrounded by WFA (PV+/WFA+ cells; C) and intensity of PV+/WFA− cells PV cells (D) at 2 or 24 h after acute or repeated saline or cocaine exposure. N = 6–8 rats/group. *p < 0.05, compared to saline group.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Cocaine alters intensity of GABAergic (GAD65/67) puncta near PV neurons surrounded by PNNs in the prelimbic PFC. Cells were visualized with confocal microscopy and analyzed using Imaris segmentation tools. A, Representative PV neuron (red) surrounded by a PNN labeled with WFA (blue). B, The PV neuron is traced and a surface is created. C, The Mask Channel function was used to isolate GAD65/67 labeling to the area outside of the PV neuronal surface, and GAD65/67-labeled puncta (green arrowheads) were identified. D, GAD65/67-labeled puncta (green arrowheads) were then thresholded using the Imaris Spots tool. Spots that met the size criteria and were located adjacent to the PV neuron surface were included in the analysis (green arrows). E, F, VGluT1-labeled puncta (magenta arrowheads) were segmented separately using the same protocol (E), and VGluT1 spots meeting our size and location criteria were included in the analysis (magenta arrows; F). G–I, One day of cocaine exposure increases GAD 65/67 puncta (saline, N = 3, 45 cells; cocaine, N = 3, 49 cells; G), no change in VGluT1 puncta (H), and a trend toward an increase in the ratio of GAD65/67 to VGluT1 puncta (I). J, One day of cocaine exposure decreases PV cell volume. K–M, Five days of cocaine exposure increases GAD 65/67 puncta (saline, N = 4, 49 cells; cocaine, N = 6, 78 cells; K), yields no change in VGluT1 puncta (L), and increases the ratio of GAD65/67 to VGluT1 puncta (M). N, Five days of cocaine exposure does not alter PV cell volume. Data from bar graphs are the mean ± SEM. Scale bar, 3 µm. *p < 0.05 and #p < 0.1, compared with saline controls.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Intrinsic and synaptic properties of FSIs surrounded by PNNs exposed to cocaine in the prelimbic PFC. Data are the mean ± SEM. Fast-spiking interneuron properties 2 h following 1 or 5 d of saline or cocaine exposure. A, Recording locations in layer V of the prelimbic PFC. B, Action potentials recorded from FSIs surrounded by WFA. *p < 0.0001 comparing between saline and both cocaine groups; +p < 0.0001 comparing between saline and 1 d of cocaine exposure. C, Trace examples of recorded FSIs at 800 pA. Calibration: 50 ms, 50 mV. D, Trace example of first elicited action potential (AP). Dashed = saline exposure; gray = 1 d of cocaine exposure; black = 5 d of cocaine exposure. Calibration: 20 mV, 500 μs. E–K, Intrinsic properties were as follows: resting membrane potential (E), input resistance (F), AP threshold (G), rise time (H), AP amplitude (I), AP half-width (J), and AP afterhyperpolarization potential (K), comparing acute and repeated cocaine (C) to acute and repeated saline controls (S), respectively. L, Cumulative frequency plots of mEPSC amplitudes and interevent intervals. Trace examples are shown below. Calibration: 50 pA, 500 μs. M, Cumulative frequency plots of mIPSC amplitudes and interevent intervals. Trace examples are shown below. The number of cells/number of rats used is shown (E, L, M).

Tables

  • Figures
  • Extended Data
    • View popup
    Table 1.

    Number of PV cells surrounded by WFA in prelimbic and infralimbic PFC after 1 or 5 d of saline or cocaine

    GroupDrug RegionPV+/WFA+
    1 d 2 hSalPrelimbic88 ± 14
    Coc77 ± 8
    SalInfralimbic61 ± 6
    Coc51 ± 7
    5 d 2 hSalPrelimbic80 ± 12
    Coc70 ± 10
    SalInfralimbic61 ± 8
    Coc66 ± 8
    1 d 24 hSalPrelimbic89 ± 18
    Coc91 ± 21
    SalInfralimbic45 ± 5
    Coc43 ± 11
    5 d 24 hSalPrelimbic102 ± 16
    Coc108 ± 14
    SalInfralimbic67 ± 8
    Coc49 ± 9
    • Coc, Cocaine; Sal, saline.

    • View popup
    Table 2.

    Composition of GAGs in mPFC after 1 or 5 d of saline or cocaine

    1 d5 d
    GroupSalineCocaineSalineCocaine
    Total GAG compositionHS17.9 ± 4.1%19.3 ± 6.9%18.4 ± 2.2%17.2 ± 2.7%
    CS54.3 ± 8.251.7 ± 11.652.8 ± 4.156.8 ± 4.4
    HA27.8 ± 10.629.0 ± 13.628.8 ± 6.226.0 ± 6.9
    HS compositionTriS2.3 ± 1.2%2.2 ± 1.6%1.6 ± 0.4%1.8 ± 0.2%
    NS6S4.4 ± 1.3%3.9 ± 1.83.9 ± 0.74.2 ± 0.6
    NS2S11.9 ± 3.5%10.8 ± 4.18.7 ± 1.210.5 ± 0.8
    NS17.8 ± 2.916.7 ± 4.817.7 ± 1.318.2 ± 1.1
    2S6S0.1 ± 0.10.2 ± 0.10.1 ± 0.10.1 ± 0.1
    6S2.7 ± 1.22.6 ± 1.32.8 ± 0.53.0 ± 0.3
    2S0.5 ± 0.10.3 ± 0.20.5 ± 0.10.4 ± 0.1
    0S60.4 ± 8.963.2 ± 12.464.6 ± 3.661.7 ± 2.7
    CS composition2S4S0.2 ± 0.1%0.2 ± 0.1%0.2 ± 0.1%0.3 ± 0.1%
    2S6S1.1 ± 0.51.0 ± 0.50.8 ± 0.31.0 ± 0.3
    4S6S1.1 ± 0.21.1 ± 0.30.9 ± 0.11.0 ± 0.1
    4S89.8 ± 3.989.5 ± 3.490.3 ± 1.589.1 ± 2.0
    6S2.4 ± 0.91.9 ± 0.82.2 ± 0.52.7 ± 0.9
    2S0.2 ± 0.10.1 ± 0.10.2 ± 0.10.1 ± 0.1
    0S5.2 ± 2.56.1 ± 3.75.3 ± 1.55.8 ± 0.9

Extended Data

  • Figures
  • Tables
  • Figure 1-1

    Table showing significant correlations between cocaine-induced locomotor activity and WFA or PV intensity in single- and double-labeled cells in the prelimbic and infralimbic PFC. Download Figure 1-1, DOC file.

Back to top

In this issue

eneuro: 5 (5)
eNeuro
Vol. 5, Issue 5
September/October 2018
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cocaine Exposure Modulates Perineuronal Nets and Synaptic Excitability of Fast-Spiking Interneurons in the Medial Prefrontal Cortex
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Cocaine Exposure Modulates Perineuronal Nets and Synaptic Excitability of Fast-Spiking Interneurons in the Medial Prefrontal Cortex
Megan L. Slaker, Emily T. Jorgensen, Deborah M. Hegarty, Xinyue Liu, Yan Kong, Fuming Zhang, Robert J. Linhardt, Travis E. Brown, Sue A. Aicher, Barbara A. Sorg
eNeuro 1 October 2018, 5 (5) ENEURO.0221-18.2018; DOI: 10.1523/ENEURO.0221-18.2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Cocaine Exposure Modulates Perineuronal Nets and Synaptic Excitability of Fast-Spiking Interneurons in the Medial Prefrontal Cortex
Megan L. Slaker, Emily T. Jorgensen, Deborah M. Hegarty, Xinyue Liu, Yan Kong, Fuming Zhang, Robert J. Linhardt, Travis E. Brown, Sue A. Aicher, Barbara A. Sorg
eNeuro 1 October 2018, 5 (5) ENEURO.0221-18.2018; DOI: 10.1523/ENEURO.0221-18.2018
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
    • Synthesis
    • Author Response
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • cocaine
  • interneurons
  • parvalbumin
  • perineuronal nets
  • prefrontal cortex

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • A Very Fast Time Scale of Human Motor Adaptation: Within Movement Adjustments of Internal Representations during Reaching
  • Hsc70 Ameliorates the Vesicle Recycling Defects Caused by Excess α-Synuclein at Synapses
  • TrkB Signaling Influences Gene Expression in Cortistatin-Expressing Interneurons
Show more New Research

Disorders of the Nervous System

  • GABAB Receptor signaling in CA1 Pyramidal Cells is not Regulated by Aging in the APP/PS1 Mouse Model of Amyloid Pathology
  • C. elegans Spastin/spas-1 Is Required for Axon Regeneration and Maintenance
  • The Single-Prolonged Stress Model Fails to Produce Behavioral or Corticosterone Alterations in Rats
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2026 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.